Signature Estate & Investment Advisors LLC Sells 3,559 Shares of UnitedHealth Group Incorporated (UNH)

Signature Estate & Investment Advisors LLC decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.6% in the 2nd quarter, according to its most recent 13F filing with the SEC. The fund owned 96,558 shares of the healthcare conglomerate’s stock after selling 3,559 shares during the period. UnitedHealth Group makes up 2.1% of Signature Estate & Investment Advisors LLC’s holdings, making the stock its 11th largest position. Signature Estate & Investment Advisors LLC’s holdings in UnitedHealth Group were worth $17,904,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the business. Marshall Wace LLP increased its position in shares of UnitedHealth Group by 441.4% in the 2nd quarter. Marshall Wace LLP now owns 13,935 shares of the healthcare conglomerate’s stock valued at $2,578,000 after buying an additional 11,361 shares in the last quarter. American Century Companies Inc. increased its position in shares of UnitedHealth Group by 16.9% in the 2nd quarter. American Century Companies Inc. now owns 4,703,113 shares of the healthcare conglomerate’s stock valued at $872,051,000 after buying an additional 681,111 shares in the last quarter. Schwab Charles Investment Management Inc. increased its position in shares of UnitedHealth Group by 5.3% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 3,656,975 shares of the healthcare conglomerate’s stock valued at $678,077,000 after buying an additional 183,401 shares in the last quarter. Essex Financial Services Inc. increased its position in shares of UnitedHealth Group by 12.3% in the 2nd quarter. Essex Financial Services Inc. now owns 8,846 shares of the healthcare conglomerate’s stock valued at $1,640,000 after buying an additional 967 shares in the last quarter. Finally, Factory Mutual Insurance Co. increased its position in shares of UnitedHealth Group by 20.9% in the 2nd quarter. Factory Mutual Insurance Co. now owns 416,600 shares of the healthcare conglomerate’s stock valued at $77,245,000 after buying an additional 72,000 shares in the last quarter. Institutional investors own 86.20% of the company’s stock.

A number of analysts recently commented on the stock. Leerink Swann restated a “buy” rating and issued a $240.00 price objective (up previously from $225.00) on shares of UnitedHealth Group in a research report on Wednesday, October 18th. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 target price for the company in a research note on Thursday, September 21st. Cantor Fitzgerald upped their target price on shares of UnitedHealth Group to $225.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 18th. Oppenheimer upped their target price on shares of UnitedHealth Group from $215.00 to $205.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 18th. Finally, Wells Fargo & Company reaffirmed an “outperform” rating and issued a $245.00 target price (up from $230.00) on shares of UnitedHealth Group in a research note on Wednesday, November 29th. Three research analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $224.56.

Shares of UnitedHealth Group Incorporated (NYSE:UNH) traded down $0.15 during trading hours on Thursday, reaching $219.94. 2,397,400 shares of the company traded hands, compared to its average volume of 3,116,121. UnitedHealth Group Incorporated has a twelve month low of $156.09 and a twelve month high of $231.77. The firm has a market cap of $213,282.06, a P/E ratio of 22.93, a P/E/G ratio of 1.63 and a beta of 0.66. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The business had revenue of $50.32 billion during the quarter, compared to the consensus estimate of $50.38 billion. During the same period last year, the business posted $2.17 EPS. UnitedHealth Group’s revenue was up 8.7% on a year-over-year basis. equities research analysts anticipate that UnitedHealth Group Incorporated will post 9.99 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Friday, December 1st will be paid a $0.75 dividend. The ex-dividend date of this dividend is Thursday, November 30th. This represents a $3.00 annualized dividend and a yield of 1.36%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 33.26%.

In related news, insider Thomas E. Roos sold 975 shares of the firm’s stock in a transaction dated Thursday, October 19th. The shares were sold at an average price of $205.47, for a total value of $200,333.25. Following the completion of the sale, the insider now directly owns 24,630 shares in the company, valued at approximately $5,060,726.10. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Larry C. Renfro sold 50,574 shares of the stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the completion of the transaction, the insider now directly owns 195,625 shares in the company, valued at $38,755,268.75. The disclosure for this sale can be found here. Insiders sold a total of 62,606 shares of company stock valued at $12,677,525 over the last quarter. 0.89% of the stock is currently owned by company insiders.

WARNING: “Signature Estate & Investment Advisors LLC Sells 3,559 Shares of UnitedHealth Group Incorporated (UNH)” was published by Ticker Report and is the property of of Ticker Report. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international copyright and trademark law. The legal version of this report can be viewed at https://www.tickerreport.com/banking-finance/3080212/signature-estate-investment-advisors-llc-sells-3559-shares-of-unitedhealth-group-incorporated-unh.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.